logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9290450 B1

PDFFull Text
Date of Patent:
Mar. 22, 2016

Filed:

Apr. 28, 2014

Compounds and methods for treating inflammatory and fibrotic disorders

Applicant:

Intermune, Inc., Brisbane, CA (US);

Inventors:

Karl Kossen, Brisbane, CA (US);

Scott D. Seiwert, Seattle, WA (US);

Vladimir Serebryany, Burlingame, CA (US);

Donald Ruhrmund, San Francisco, CA (US);

Leonid D. Beigelman, San Mateo, CA (US);

Luca Francesco Mario Raveglia, Milan, IT;

Stefania Vallese, Cardano al Campo, IT;

Ivana Bianchi, Fagnano Olona, IT;

Tao Hu, Shanghai, CN;

Assignee:

InterMune, Inc., Brisbane, CA (US);

Attorney:

Knobbe Martens Olson & Bear LLP

Primary Examiner:

Zinna Northington Davis

Int. Cl.
CPC ...
C07D 213/22 (2006.01); C07D 241/18 (2006.01); C07D 401/04 (2006.01); C07D 405/04 (2006.01); C07D 413/04 (2006.01); C07D 417/04 (2006.01); C07D 213/63 (2006.01); C07D 213/64 (2006.01); C07D 213/71 (2006.01); C07D 237/14 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01); C07D 213/69 (2006.01); C07D 213/85 (2006.01); C07D 239/36 (2006.01); C07D 239/54 (2006.01); C07D 251/10 (2006.01); C07D 405/14 (2006.01); C07D 409/04 (2006.01); C07D 413/14 (2006.01);
U.S. Cl.
CPC ...
C07D 213/63 (2013.01); C07D 213/22 (2013.01); C07D 213/64 (2013.01); C07D 213/69 (2013.01); C07D 213/71 (2013.01); C07D 213/85 (2013.01); C07D 237/14 (2013.01); C07D 239/36 (2013.01); C07D 239/54 (2013.01); C07D 241/18 (2013.01); C07D 251/10 (2013.01); C07D 401/04 (2013.01); C07D 405/04 (2013.01); C07D 405/14 (2013.01); C07D 409/04 (2013.01); C07D 413/04 (2013.01); C07D 413/14 (2013.01); C07D 417/04 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01);
Abstract

Disclosed are compounds and methods for treating inflammatory and fibrotic disorders, including methods of modulating a stress activated protein kinase (SAPK) system with an active compound, wherein the active compound exhibits low potency for inhibition of the p38 MAPK; and wherein the contacting is conducted at a SAPK-modulating concentration that is at a low percentage inhibitory concentration for inhibition of the p38 MAPK by the compound. Also disclosed are derivatives and analogs of pirfenidone, useful for modulating a stress activated protein kinase (SAPK) system.

Find Patent Forward Citations

Loading…